Networks controlling mRNA decay in the immune system

Wiley Interdisciplinary Reviews: RNA

Volumn 1, Issue 3, 2010, Pages 432-456

  Schott, Johanna ^a   Stoecklin, Georg ^a  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE URIDINE RICH ELEMENT; AUTOANTIBODY; BRF1 PROTEIN; BRF2 PROTEIN; CHEMOKINE; CYTOKINE; ENDONUCLEASE; ENDOTOXIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HUR PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; MICRORNA; MICRORNA 101; MICRORNA 155; MICRORNA 26; PEPTIDYLPROLYL ISOMERASE PIN1; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN KINASE C DELTA; RNA BINDING PROTEIN; RNA BINDING PROTEIN KSRP; ROQUIN PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TRISTETRAPROLIN; UNCLASSIFIED DRUG; URIDINE; VASCULOTROPIN;

3' UNTRANSLATED REGION; ADAPTIVE IMMUNITY; ADENYLATION; AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; AUTOIMMUNITY; BINDING SITE; CELL ORGANELLE; CELL P BODY; CELL STRESS GRANULE; CYTOKINE PRODUCTION; DEADENYLATION KINETICS; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REGULATORY NETWORK; GENETIC CODE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LUPUS LIKE SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA BINDING; RNA CLEAVAGE; RNA DEGRADATION; RNA METABOLISM; RNA STABILITY; RNA STRUCTURE; RNA TRANSCRIPTION; RNA TRANSLATION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REGULATORY RNA SEQUENCE;

ANIMALS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; IMMUNE SYSTEM; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA STABILITY; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84857464812     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.13     Document Type: Review

References (247)

1. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009, 27: 693-733.
2. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008, 8: 837-848.
3. Keene JD, Tenenbaum SA. Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 2002, 9: 1161-1167.
4. Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 2010, 10: 24-35.
5. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, et al. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 1986, 83: 1670-1674.
6. Shaw G, Kamen R. A conserved AU sequence from the 3'untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46: 659-667.
7. Hao S, Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 2009, 10: 281-288.
8. Raghavan A, Ogilvie RL, Reilly C, Abelson ML, Raghavan S, et al. Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes. Nucleic Acids Res 2002, 30: 5529-5538.
9. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136: 26-36.
10. Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai TH, et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008, 28: 630-638.
11. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316: 608-611.
12. Sauer I, Schaljo B, Vogl C, Gattermeier I, Kolbe T, et al. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 2006, 107: 4790-4797.
13. Pastore S, Mascia F, Mariotti F, Dattilo C, Mariani V, et al. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 2005, 174: 5047-5056.
14. Poon M, Liu B, Taubman MB. Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol Cell Biol 1999, 19: 6471-6478.
15. Marcais A, Tomkowiak M, Walzer T, Coupet CA, Ravel-Chapuis A, Marvel J. Maintenance of CCL5 mRNA stores by post-effector and memory CD8 T cells is dependent on transcription and is coupled to increased mRNA stability. Eur J Immunol 2006, 36: 2745-2754.
16. Atasoy U, Curry SL, Lopez de Silanes I, Shyu AB, Casolaro V, et al. Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR. J Immunol 2003, 171: 4369-4378.
17. Ford GS, Barnhart B, Shone S, Covey LR. Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J Immunol 1999, 162: 4037-4044.
18. Vavassori S, Shi Y, Chen CC, Ron Y, Covey LR. In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells. Eur J Immunol 2009, 39: 2224-2232.
19. Barnhart B, Kosinski PA, Wang Z, Ford GS, Kiledjian M, et al. Identification of a complex that binds to the CD1543′ untranslated region: implications for a role in message stability during T cell activation. J Immunol 2000, 165: 4478-4486.
20. Kosinski PA, Laughlin J, Singh K, Covey LR. A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA. J Immunol 2003, 170: 979-988.
21. Singh K, Laughlin J, Kosinski PA, Covey LR. Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells. J Immunol 2004, 173: 976-985.
22. Hamilton BJ, Genin A, Cron RQ, Rigby WF. Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression. Mol Cell Biol 2003, 23: 510-525.
23. Rigby WF, Waugh MG, Hamilton BJ. Characterization of RNA binding proteins associated with CD40 ligand (CD154) mRNA turnover in human T lymphocytes. J Immunol 1999, 163: 4199-4206.
24. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, et al. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 2000, 20: 4265-4274.
25. Ridley SH, Dean JL, Sarsfield SJ, Brook M, Clark AR, et al. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett 1998, 439: 75-80.
26. Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 1994, 269: 11769-11775.
27. Dixon DA, Balch GC, Kedersha N, Anderson P, Zimmerman GA, Beauchamp RD, et al. Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J Exp Med 2003, 198: 475-481.
28. Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 2003, 11: 113-126.
29. Datta S, Biswas R, Novotny M, Pavicic PG Jr, Herjan T, et al. Tristetraprolin regulates CXCL1 (KC) mRNA stability. J Immunol 2008, 180: 2545-2552.
30. Sirenko OI, Lofquist AK, DeMaria CT, Morris JS, Brewer G, et al. Adhesion-dependent regulation of an A + U-rich element-binding activity associated with AUF1. Mol Cell Biol 1997, 17: 3898-3906.
31. Biswas R, Datta S, Gupta JD, Novotny M, Tebo J, et al. Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10. J Immunol 2003, 170: 6202-6208.
32. Stoeckle MY. Post-transcriptional regulation of gro alpha, beta, gamma, and IL-8 mRNAs by IL-1 beta. Nucleic Acids Res 1991, 19: 917-920.
33. Datta S, Novotny M, Pavicic PG Jr, Zhao C, Herjan T, et al. IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence. J Immunol 2010, 184: 1484-1491.
34. Rousseau S, Morrice N, Peggie M, Campbell DG, Gaestel M, et al. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J 2002, 21: 6505-6514.
35. Vockerodt M, Pinkert D, Smola-Hess S, Michels A, Ransohoff RM, et al. The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulation. Int J Cancer 2005, 114: 598-605.
36. Frasca D, Landin AM, Alvarez JP, Blackshear PJ, Riley RL, et al. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol 2007, 179: 918-927.
37. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007, 179: 5082-5089.
38. Koeffler HP, Gasson J, Tobler A. Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol Cell Biol 1988, 8: 3432-3438.
39. Brown CY, Lagnado CA, Goodall GJ. A cytokine mRNA-destabilizing element that is structurally and functionally distinct from A + U-rich elements. Proc Natl Acad Sci USA 1996, 93: 13721-13725.
40. Putland RA, Sassinis TA, Harvey JS, Diamond P, Coles LS, et al. RNA destabilization by the granulocyte colony-stimulating factor stem-loop destabilizing element involves a single stem-loop that promotes deadenylation. Mol Cell Biol 2002, 22: 1664-1673.
41. Carballo E, Lai WS, Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 2000, 95: 1891-1899.
42. Bickel M, Cohen RB, Pluznik DH. Post-transcriptional regulation of granulocyte-macrophage colony- stimulating factor synthesis in murine T cells. J Immunol 1990, 145: 840-845.
43. Esnault S, Malter JS. Primary peripheral blood eosinophils rapidly degrade transfected granulocyte-macrophage colony-stimulating factor mRNA. J Immunol 1999, 163: 5228-5234.
44. Grosset C, Boniface R, Duchez P, Solanilla A, Cosson B, et al. In vivo studies of translational repression mediated by the granulocyte-macrophage colony-stimulating factor AU-rich element. J Biol Chem 2004, 279: 13354-13362.
45. Yu D, Tan AH, Hu X, Athanasopoulos V, Simpson N, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007, 450: 299-303.
46. Whittemore L-A, Maniatis T. Postinduction turnoff of beta-interferon gene expression. Mol Cell Biol 1990, 64: 1329-1337.
47. Raj NB, Pitha PM. Two levels of regulation of beta-interferon gene expression in human cells. Proc Natl Acad Sci USA 1983, 80: 3923-3927.
48. Lindsten T, June CH, Ledbetter JA, Stella G, Thompson GB. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989, 244: 339-343.
49. Hodge DL, Martinez A, Julias JG, Taylor LS, Young HA. Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control. Mol Cell Biol 2002, 22: 1742-1753.
50. Mavropoulos A, Sully G, Cope AP, Clark AR. Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells. Blood 2005, 105: 282-288.
51. Banerjee A, Schambach F, Dejong CS, Hammond SM, Reiner SL. Micro-RNA-155 inhibits IFN-gamma signaling in CD4(+) T cells. Eur J Immunol 2009, 40: 225-231.
52. Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, et al. LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. Faseb J 2009, 23: 2898-2908.
53. Lu JY, Sadri N, Schneider RJ. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev 2006, 20: 3174-3184.
54. Mizgalska D, Wegrzyn P, Murzyn K, Kasza A, Koj A, et al. Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1beta mRNA. FEBS Lett 2009, 276: 7386-7399.
55. Fenton MJ, Vermeulen MW, Clark BD, Webb AC, Auron PE. Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J Immunol 1988, 140: 2267-2273.
56. Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, et al. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci USA 1988, 85: 1204-1208.
57. Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, et al. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J Immunol 2005, 174: 953-961.
58. Chen CY, Del Gatto-Konczak F, Wu Z, Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998, 280: 1945-1949.
59. Shim J, Lim H, Yates JR, Karin M. Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol Cell 2002, 10: 1331-1344.
60. Shi L, Godfrey WR, Lin J, Zhao G, Kao PN. NF90 regulates inducible IL-2 gene expression in T cells. J Exp Med 2007, 204: 971-977.
61. Stoecklin G, Ming XF, Looser R, Moroni C. Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol Cell Biol 2000, 20: 3753-3763.
62. Wodnar-Filipowicz A, Moroni C. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc Natl Acad Sci USA 1990, 87: 777-781.
63. Nair AP, Hahn S, Banholzer R, Hirsch HH, Moroni C. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature 1994, 369: 239-242.
64. Yarovinsky TO, Butler NS, Monick MM, Hunninghake GW. Early exposure to IL-4 stabilizes IL-4 mRNA in CD4+ T cells via RNA-binding protein HuR. J Immunol 2006, 177: 4426-4435.
65. Stoecklin G, Stoeckle P, Lu M, Muehlemann O, Moroni C. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 2001, 7: 1578-1588.
66. Akashi M, Loussararian AH, Adelman DC, Saito M, Koeffler HP. Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation. J Clin Invest 1990, 85: 121-129.
67. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, et al. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 1999, 18: 4969-4980.
68. Neininger A, Kontoyiannis D, Kotlyarov A, Winzen R, Eckert R, et al. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem 2002, 277: 3065-3068.
69. Matsushita K, Takeuchi O, Standley DM, Kumagai Y, Kawagoe T, et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 2009, 458: 1185-1190.
70. Paschoud S, Dogar AM, Kuntz C, Grisoni-Neupert B, Richman L, et al. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol Cell Biol 2006, 26: 8228-8241.
71. Jones MR, Quinton LJ, Blahna MT, Neilson JR, Fu S, et al. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat Cell Biol 2009, 11: 1157-1163.
72. Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffmann E, et al. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 1999, 19: 6742-6753.
73. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, et al. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 2008, 283: 11689-11699.
74. Bamba S, Andoh A, Yasui H, Makino J, Kim S, et al. Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1- and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol 2003, 285: G529-G538.
75. Yang L, Yang YC. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J Biol Chem 1994, 269: 32732-32739.
76. Casolaro V, Fang X, Tancowny B, Fan J, Wu F, et al. Posttranscriptional regulation of IL-13 in T cells: role of the RNA-binding protein HuR. J Allergy Clin Immunol 2008, 121: 853-859 e854.
77. Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 2004, 381: 503-510.
78. Di Marco S, Mazroui R, Dallaire P, Chittur S, Tenenbaum SA, et al. NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Mol Cell Biol 2005, 25: 6533-6545.
79. Lahti A, Jalonen U, Kankaanranta H, Moilanen E. c-Jun NH2-terminal kinase inhibitor anthra(1, 9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. Mol Pharmacol 2003, 64: 308-315.
80. Linker K, Pautz A, Fechir M, Hubrich T, Greeve J, et al. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res 2005, 33: 4813-4827.
81. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103: 12481-12486.
82. Hou J, Wang P, Lin L, Liu X, Ma F, An H, et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009, 183: 2150-2158.
83. Tang Y, Luo X, Cui H, Ni X, Yuan M, et al. microRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009, 60: 1065-1075.
84. Huwiler A, Akool el S, Aschrafi A, Hamada FM, Pfeilschifter J, Eberhardt W. ATP potentiates interleukin-1 beta-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR. J Biol Chem 2003, 278: 51758-51769.
85. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A 2009, 106: 5282-5287.
86. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010, 11: 141-147.
87. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007, 27: 847-859.
88. Porter JF, Vavassori S, Covey LR. A polypyrimidine tract-binding protein-dependent pathway of mRNA stability initiates with CpG activation of primary B cells. J Immunol 2008, 181: 3336-3345.
89. Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, et al. Onco-miR-155 targets SHIP1 to promote TNFa-dependent growth of B cell lymphomas. Embo Mol Med 2009, 1: 288-295.
90. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 2009, 106: 7113-7118.
91. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009, 31: 220-231.
92. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990, 171: 465-475.
93. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281: 1001-1005.
94. Brook M, Sully G, Clark AR, Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett 2000, 483: 57-61.
95. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005, 120: 623-634.
96. Stoecklin G, Lu M, Rattenbacher B, Moroni C. A constitutive decay element promotes tumor necrosis factor alpha mRNA degradation via an AU-rich element-independent pathway. Mol Cell Biol 2003, 23: 3506-3515.
97. Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J Clin Invest 1995, 95: 264-271.
98. Croft D, McIntyre P, Wibulswas A, Kramer I. Sustained elevated levels of VCAM-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability. Am J Pathol 1999, 154: 1149-1158.
99. Levy NS, Chung S, Furneaux H, Levy AP. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 1998, 273: 6417-6423.
100. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995, 270: 19761-19766.
101. Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA, et al. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell 1999, 10: 907-919.
102. Coles LS, Bartley MA, Bert A, Hunter J, Polyak S, et al. A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Potential role in mRNA stabilization. Eur J Biochem 2004, 271: 648-660.
103. Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 2005, 33: 7138-7150.
104. Eberhardt W, Doller A, Akool el S, Pfeilschifter J. Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther 2007, 114: 56-73.
105. Bakheet T, Williams BR, Khabar KS. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 2006, 34: D111-D114.
106. Stoecklin G, Hahn S, Moroni C. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J Biol Chem 1994, 269: 28591-28597.
107. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999, 10: 387-398.
108. Tudor C, Marchese FP, Hitti E, Aubareda A, Rawlinson L, et al. The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages. FEBS Lett 2009, 583: 1933-1938.
109. Chen C-YA, Shyu A-B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995, 20: 465-470.
110. Zubiaga AM, Belasco JG, Greenberg ME. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 1995, 15: 2219-2230.
111. Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 2001, 29: 246-254.
112. Yang E, van Nimwegen E, Zavolan M, Rajewsky N, Schroeder M, et al. Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. Genome Res 2003, 13: 1863-1872.
113. Yamashita A, Chang TC, Yamashita Y, Zhu W, Zhong Z, et al. Concerted action of poly(A) nucleases and decapping enzyme in mammalian mRNA turnover. Nat Struct Mol Biol 2005, 12: 1054-1063.
114. Schwede A, Ellis L, Luther J, Carrington M, Stoecklin G, Clayton C. A role for Caf1 in mRNA deadenylation and decay in trypanosomes and human cells. Nucleic Acids Res 2008, 36: 3374-3388.
115. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 2001, 107: 451-464.
116. Mukherjee D, Gao M, O'Connor JP, Raijmakers R, Pruijn G, et al. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 2002, 21: 165-174.
117. Lebreton A, Tomecki R, Dziembowski A, Seraphin B. Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature 2008, 456: 993-996.
118. Raijmakers R, Schilders G, Pruijn GJ. The exosome, a molecular machine for controlled RNA degradation in both nucleus and cytoplasm. Eur J Cell Biol 2004, 83: 175-183.
119. Gao M, Wilusz CJ, Peltz SW, Wilusz J. A novel mRNA-decapping activity in HeLa cytoplasmic extracts is regulated by AU-rich elements. EMBO J 2001, 20: 1134-1143.
120. Fenger-Gron M, Fillman C, Norrild B, Lykke-Andersen J. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol Cell 2005, 20: 905-915.
121. Stoecklin G, Mayo T, Anderson P. ARE-mRNA degradation requires the 5'-3′ decay pathway. EMBO Rep 2006, 7: 72-77.
122. Anderson P. Post-transcriptional control of cytokine production. Nat Immunol 2008, 9: 353-359.
123. Raineri I, Wegmueller D, Gross B, Certa U, Moroni C. Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res 2004, 32: 1279-1288.
124. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, et al. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 2004, 23: 3092-3102.
125. Loflin P, Chen CY, Shyu AB. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev 1999, 13: 1884-1897.
126. Sarkar B, Xi Q, He C, Schneider RJ. Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol Cell Biol 2003, 23: 6685-6693.
127. Xu N, Chen CY, Shyu AB. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol Cell Biol 2001, 21: 6960-6971.
128. Pautz A, Linker K, Altenhofer S, Heil S, Schmidt N, Art J, et al. Similar regulation of human inducible nitric-oxide synthase expression by different isoforms of the RNA-binding protein AUF1. J Biol Chem 2009, 284: 2755-2766.
129. Dean JL, Sully G, Wait R, Rawlinson L, Clark AR, et al. Identification of a novel AU-rich-element-binding protein which is related to AUF1. Biochem J 2002, 366: 709-719.
130. Lai WS, Carballo E, Thorn JM, Kennington EA, Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J Biol Chem 2000, 275: 17827-17837.
131. Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, et al. Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J 2002, 21: 4709-4718.
132. Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, et al. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 2004, 23: 8673-8680.
133. Stumpo DJ, Broxmeyer HE, Ward T, Cooper S, Hangoc G, et al. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood 2009, 114: 2401-2410.
134. Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, et al. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell 2008, 29: 263-270.
135. Ming XF, Stoecklin G, Lu M, Looser R, Moroni C. Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-Kinase and p38 mitogen-activated protein kinase. Mol Cell Biol 2001, 21: 5778-5789.
136. Fan XC, Steitz JA. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 1998, 17: 3448-3460.
137. Peng SS, Chen CY, Xu N, Shyu AB. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 1998, 17: 3461-3470.
138. Ford LP, Watson J, Keene JD, Wilusz J. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 1999, 13: 188-201.
139. Rodriguez-Pascual F, Hausding M, Ihrig-Biedert I, Furneaux H, Levy AP, et al. Complex contribution of the 3'-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J Biol Chem 2000, 275: 26040-26049.
140. Winzen R, Gowrishankar G, Bollig F, Redich N, Resch K, Holtmann H. Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol 2004, 24: 4835-4847.
141. Cok SJ, Acton SJ, Morrison AR. The proximal region of the 3'-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J Biol Chem 2003, 278: 36157-36162.
142. Gherzi R, Lee KY, Briata P, Wegmuller D, Moroni C, et al. A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol Cell 2004, 14: 571-583.
143. Winzen R, Thakur BK, Dittrich-Breiholz O, Shah M, Redich N, et al. Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets. Mol Cell Biol 2007, 27: 8388-8400.
144. Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, et al. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000, 14: 1236-1248.
145. Anderson JR, Mukherjee D, Muthukumaraswamy K, Moraes KC, Wilusz CJ, et al. Sequence-specific RNA binding mediated by the RNase PH domain of components of the exosome. RNA 2006, 12: 1810-1816.
146. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, et al. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 1999, 19: 4311-4323.
147. Ogilvie RL, Sternjohn JR, Rattenbacher B, Vlasova IA, Williams DA, et al. Tristetraprolin mediates interferon-gamma mRNA decay. J Biol Chem 2009, 284: 11216-11223.
148. Patil CS, Liu M, Zhao W, Coatney DD, Li F, et al. Targeting mRNA stability arrests inflammatory bone loss. Mol Ther 2008, 16: 1657-1664.
149. Capowski EE, Esnault S, Bhattacharya S, Malter JS. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J Immunol 2001, 167: 5970-5976.
150. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996, 4: 445-454.
151. Cao H, Tuttle JS, Blackshear PJ. Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein. J Biol Chem 2004, 279: 21489-21499.
152. Raghavan A, Robison RL, McNabb J, Miller CR, Williams DA, Bohjanen PR. HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J Biol Chem 2001, 276: 47958-47965.
153. Varnum BC, Ma QF, Chi TH, Fletcher B, Herschman HR. The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. Mol Cell Biol 1991, 11: 1754-1758.
154. Ramos SB, Stumpo DJ, Kennington EA, Phillips RS, Bock CB, et al. The CCCH tandem zinc-finger protein Zfp36l2 is crucial for female fertility and early embryonic development. Development 2004, 131: 4883-4893.
155. Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, et al. The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn 2006, 235: 3144-3155.
156. Min H, Turck CW, Nikolic JM, Black DL. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev 1997, 11: 1023-1036.
157. Brewer G. An A + U-rich element RNA-binding factor regulates c-myc stability in vitro. Mol Cell Biol 1991, 11: 2460-2466.
158. Zhang W, Wagner BJ, Ehrenman K, Schaefer AW, DeMaria CT, et al. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol Cell Biol 1993, 13: 7652-7665.
159. Sadri N, Schneider RJ. Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease. J Invest Dermatol 2009, 129: 657-670.
160. Sadri N, Lu JY, Badura ML, Schneider RJ. Role of AUF1 in splenic size and follicular B cell maintenance. BMC Immunol 2010, 11: 1.
161. Ma W-J, Cheng S, Campbell C, Wright A, Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 1996, 271: 8144-8151.
162. Antic D, Keene JD. Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet 1997, 61: 273-278.
163. Katsanou V, Papadaki O, Milatos S, Blackshear PJ, Anderson P, et al. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell 2005, 19: 777-789.
164. Wang JG, Collinge M, Ramgolam V, Ayalon O, Fan XC, et al. LFA-1-dependent HuR nuclear export and cytokine mRNA stabilization in T cell activation. J Immunol 2006, 176: 2105-2113.
165. Doller A, Akool el S, Huwiler A, Muller R, Radeke HH, et al. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol 2008, 28: 2608-2625.
166. Papadaki O, Milatos S, Grammenoudi S, Mukherjee N, Keene JD, et al. Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR. J Immunol 2009, 182: 6779-6788.
167. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1999, 1: 94-97.
168. Dean JL, Brook M, Clark AR, Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 1999, 274: 264-269.
169. Johnson BA, Stehn JR, Yaffe MB, Blackwell TK. Cytoplasmic localization of Tristetraprolin involves 14-3-3-dependent and -independent mechanisms. J Biol Chem 2002, 277: 18029-18036.
170. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, et al. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 2004, 23: 1313-1324.
171. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, et al. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 2004, 279: 10176-10184.
172. Sun L, Stoecklin G, van Way S, Hinkovska-Galcheva V, Guo RF, et al. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem 2007, 282: 3766-3777.
173. Schmidlin M, Lu M, Leuenberger SA, Stoecklin G, Mallaun M, et al. The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J 2004, 23: 4760-4769.
174. Maitra S, Chou CF, Luber CA, Lee KY, Mann M, et al. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA 2008, 14: 950-959.
175. Benjamin D, Schmidlin M, Min L, Gross B, Moroni C. BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites. Mol Cell Biol 2006, 26: 9497-9507.
176. Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, et al. p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell 2005, 20: 891-903.
177. Gherzi R, Trabucchi M, Ponassi M, Ruggiero T, Corte G, et al. The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol 2006, 5: e5.
178. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, et al. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 2006, 26: 2399-2407.
179. Ming XF, Kaiser M, Moroni C. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EMBO J 1998, 17: 6039-6048.
180. Carpenter L, Cordery D, Biden TJ. Protein kinase Cdelta activation by interleukin-1beta stabilizes inducible nitric-oxide synthase mRNA in pancreatic beta-cells. J Biol Chem 2001, 276: 5368-5374.
181. Leppanen T, Jalonen U, Korhonen R, Tuominen RK, Moilanen E. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages. Eur J Pharmacol 2009, 628: 220-225.
182. Shen ZJ, Esnault S, Malter JS. The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils. Nat Immunol 2005, 6: 1280-1287.
183. Esnault S, Braun RK, Shen ZJ, Xiang Z, Heninger E, et al. Pin1 modulates the type 1 immune response. PLoS ONE 2007, 2: e226.
184. Esnault S, Shen ZJ, Whitesel E, Malter JS. The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J Immunol 2006, 177: 6999-7006.
185. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19: 683-765.
186. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10: 39-49.
187. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 2004, 172: 567-576.
188. El Kasmi KC, Smith AM, Williams L, Neale G, Panopoulos AD, et al. Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol 2007, 179: 7215-7219.
189. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992, 267: 23301-23308.
190. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, et al. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 2001, 20: 3760-3770.
191. Brown CY, Lagnado CA, Vadas MA, Goodall GJ. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J Biol Chem 1996, 271: 20108-20112.
192. Kishore R, Tebo JM, Kolosov M, Hamilton TA. Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J Immunol 1999, 162: 2457-2461.
193. Denys A, Udalova IA, Smith C, Williams LM, Ciesielski CJ, et al. Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. J Immunol 2002, 168: 4837-4845.
194. Hammer M, Mages J, Dietrich H, Schmitz F, Striebel F, et al. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur J Immunol 2005, 35: 2991-3001.
195. Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, et al. IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. Faseb J 2006, 20: 2112-2114.
196. Schaljo B, Kratochvill F, Gratz N, Sadzak I, Sauer I, et al. Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10. J Immunol 2009, 183: 1197-1206.
197. Khabar KS. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J Interferon Cytokine Res 2005, 25: 1-10.
198. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120: 15-20.
199. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37: 495-500.
200. Asirvatham AJ, Gregorie CJ, Hu Z, Magner WJ, Tomasi TB. MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol Immunol 2008, 45: 1995-2006.
201. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75: 855-862.
202. Olsen PH, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 1999, 216: 671-680.
203. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005, 122: 553-563.
204. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433: 769-773.
205. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455: 58-63.
206. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. The impact of microRNAs on protein output. Nature 2008, 455: 64-71.
207. Hendrickson DG, Hogan DJ, McCullough HL, Myers JW, Herschlag D, et al. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol 2009, 7: e1000238.
208. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303: 83-86.
209. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009, 11: 228-234.
210. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008, 132: 860-874.
211. Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, et al. Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 2009, 183: 2506-2512.
212. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005, 435: 452-458.
213. Hutloff A, Buchner K, Reiter K, Baelde HJ, Odendahl M, et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 2004, 50: 3211-3220.
214. Iwai H, Abe M, Hirose S, Tsushima F, Tezuka K, et al. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol 2003, 171: 2848-2854.
215. Akiba H, Takeda K, Kojima Y, Usui Y, Harada N, et al. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J Immunol 2005, 175: 2340-2348.
216. Tordjman R, Lepelletier Y, Lemarchandel V, Cambot M, Gaulard P, et al. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 2002, 3: 477-482.
217. Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, et al. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 1995, 269: 245-247.
218. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198: 1875-1886.
219. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30: 80-91.
220. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316: 604-608.
221. Tam W. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 2001, 274: 157-167.
222. Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T, et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008, 28: 621-629.
223. Liu Q, Oliveira-Dos-Santos AJ, Mariathasan S, Bouchard D, Jones J, et al. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med 1998, 188: 1333-1342.
224. Martinez-Nunez RT, Louafi F, Friedmann PS, Sanchez-Elsner T. microRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 2009, 284: 16334-16342.
225. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. microRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007, 104: 1604-1609.
226. Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009, 459: 1010-1014.
227. Balachandran S, Venkataraman T, Fisher PB, Barber GN. Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol 2007, 178: 2429-2439.
228. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 2008, 82: 10436-10443.
229. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007, 450: 1096-1099.
230. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003, 24: 358-363.
231. Guha M, Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002, 277: 32124-32132.
232. Dalpke A, Heeg K, Bartz H, Baetz A. Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology 2008, 213: 225-235.
233. Wan Y, Xiao H, Affolter J, Kim TW, Bulek K, et al. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J Biol Chem 2009, 284: 10367-10375.
234. Nahid MA, Pauley KM, Satoh M, Chan EK. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem 2009, 284: 34590-34599.
235. Eulalio A, Behm-Ansmant I, Izaurralde E. P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 2007, 8: 9-22.
236. Parker R, Sheth U. P bodies and the control of mRNA translation and degradation. Mol Cell 2007, 25: 635-646.
237. Kulkarni M, Ozgur S, Stoecklin G. On track with P-bodies. Biochem Soc Trans 2010, 38: 242-251.
238. Pauley KM, Satoh M, Pauley BA, Dominguez-Gutierrez PR, Wallet SM, et al. Formation of GW/P bodies as marker for microRNA-mediated regulation of innate immune signaling in THP-1 cells. Immunol Cell Biol 2009, 88: 205-212.
239. Anderson P, Kedersha N. Stress granules. Curr Biol 2009, 19: R397-R398.
240. Kedersha N, Stoecklin G, Ayodele M, Yacono P, Lykke-Andersen J, et al. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 2005, 169: 871-884.
241. Scheu S, Stetson DB, Reinhardt RL, Leber JH, Mohrs M, Locksley RM. Activation of the integrated stress response during T helper cell differentiation. Nat Immunol 2006, 7: 644-651.
242. Swanson BJ, Murakami M, Mitchell TC, Kappler J, Marrack P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 2002, 17: 605-615.
243. Musgrave BL, Watson CL, Haeryfar SM, Barnes CA, Hoskin DW. CD2-CD48 interactions promote interleukin-2 and interferon-gamma synthesis by stabilizing cytokine mRNA. Cell Immunol 2004, 229: 1-12.
244. Stein I, Neeman M, Shweiki D, Itin A, Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 1995, 15: 5363-5368.
245. Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996, 271: 2746-2753.
246. Liang J, Wang J, Azfer A, Song W, Tromp G, et al. A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem 2008, 283: 6337-6346.
247. Liang J, Song W, Tromp G, Kolattukudy PE, Fu M. Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation. PLoS ONE 2008, 3: e2880.